Product Image

Contributor Information

  • Name Edward Chan
  • Institute University of Florida Research Foundation

Tool Details

  • Tool name: Anti-cancer inhibitor of protein phosphotase 2A [4A9-1A2]
  • Alternate names: CIP2A
  • Tool type: Antibodies
  • Tool sub-type: Primary antibody
  • Class: Monoclonal
  • Conjugate: Unconjugated
  • Reactivity: Human ; Rat ; Mouse
  • Host: Mouse
  • Application: WB ; IP
  • Description: CIP2A is an oncoprotein that inhibits PP2A tumor suppressor activity in human malignancies by preventing degredation of c-Myc and regulates the phosphorylation of many oncoproteins. CIP2A is required for malignant cellular growth and tumor formation and is overexpressed in several human cancers: head and neck squamous cell carcimona, colon cancer, gastric cancer, breast cancer, prostate cancer, and lung caner.
  • Immunogen: MAb were generated using the C-terminal third of the recombinant human protein as antigen
  • Isotype: IgG1 kappa
  • Research area: Cancer; Cell signaling and signal transduction

  • For Research Use Only

Target Details

  • Target: Cancerous Inhibitor of Protein Phosphatase 2A
  • Target background: CIP2A is an oncoprotein that inhibits PP2A tumor suppressor activity in human malignancies by preventing degredation of c-Myc and regulates the phosphorylation of many oncoproteins. CIP2A is required for malignant cellular growth and tumor formation and is overexpressed in several human cancers: head and neck squamous cell carcimona, colon cancer, gastric cancer, breast cancer, prostate cancer, and lung caner.

Application Details

  • Application: WB ; IP

Handling

  • Format: Liquid
  • Shipping conditions: Shipping at 4°C

Documentation

References

  •   Wei et al. 2019. Oncol Lett. 17(3):3211-3218. PMID: 30867751.